Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update

Liping Liu, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Zixiao Li, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Hongyu Zhou, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wanying Duan, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Xiaochuan Huo, Neurological Disease Center, Cerebral Vascular Disease Department, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Weihai Xu, Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Shujuan Li, Department of Neurology, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Ximing Nie, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Huihui Liu, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jinjie Liu, Department of General Medicine, Dalian Municipal Central Hospital Affiliated Dalian University of Technology, Dalian, China.
Dapeng Sun, China National Clinical Research Center for Neurological Diseases, Beijing, China.
Yufei Wei, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Guitao Zhang, Department of Neurology, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Weizhuang Yuan, Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Lina Zheng, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jingyi Liu, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
David Wang, Neurovascular Division, Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.Follow
Zhongrong Miao, China National Clinical Research Center for Neurological Diseases, Beijing, China.
Yongjun Wang, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China yongjunwang@ncrcnd.org.cn.

Document Type

Article

Abstract

BACKGROUND: China is one of the countries with the highest burden of stroke. Implementing multidimensional management guidelines will help clinicians practise evidence-based care, improve patient outcomes and alleviate societal burdens. This update of the 2019 edition will provide the latest comprehensive recommendations for the diagnosis and treatment of ischaemic cerebrovascular diseases. METHODS: We conducted a comprehensive search on MEDLINE (via PubMed) up to 31 August 2023. The writing team established the recommendations through multiple rounds of online and offline discussions. Each recommendation was graded using the evidence grading algorithm developed by the Chinese Stroke Association (CSA). The draft was reviewed and finalised by the CSA Stroke Guidelines Writing Committee. RESULTS: This update included revisions of 15 existing recommendations and 136 new recommendations in the following areas of stroke care: emergency assessment and diagnosis of ischaemic cerebrovascular disease, acute-phase reperfusion therapy, evaluation of underlying mechanisms, antithrombotic therapy, prevention and treatment of complications, and risk factor management. CONCLUSIONS: This guideline updated the recommendations for the clinical management of ischaemic cerebrovascular disease from 2019.

Medical Subject Headings

Humans; Algorithms; China; Risk Factors; Stroke (diagnosis, therapy); Ischemic Stroke (therapy)

Publication Date

12-29-2023

Publication Title

Stroke and vascular neurology

E-ISSN

2059-8696

Volume

8

Issue

6

First Page

e3

PubMed ID

38158224

Digital Object Identifier (DOI)

10.1136/svn-2023-002998

Link to Full Text

Share

COinS